Researchers Seek Standardized and Safe Antidepressant Tapering Protocol
A new study promotes the use of a standardized approach to antidepressant tapering.
Danish Study Finds Better 10-year Outcomes in Patients Off Antipsychotics
Study finds that 74% of patients with a psychotic disorder off antipsychotics at end of 10 years are in remission.
SSRI Withdrawal has Social, Cognitive, and Emotional Consequences
New research finds that the non-physical aspects of withdrawal from SSRIs are often overlooked.
Listening to the Patient Voice: The Antidepressant Withdrawal Experience
Patient advocates join with researchers and service users to present first-hand experiences of antidepressant withdrawal.
Antidepressant Withdrawal: A Psychiatrist’s 30-Year Challenge to Conventional Wisdom
For thirty years, Dr. Giovanni Fava has sounded the alarm on the long-term effects of antidepressants and the risks of withdrawal, pushing back against pharmaceutical narratives.
New Guidance on Antidepressant Withdrawal for Doctors in the UK
New guidance for primary care doctors in the UK on antidepressant discontinuation acknowledges severe and long-lasting withdrawal symptoms.
Fear and Belief in “Chemical Imbalance” Prevent People from Coming Off Antidepressants
Researchers interviewed people who were given medical advice to discontinue antidepressants.
No Good Evidence That Antidepressants Prevent Relapse
Trials of antidepressants for relapse prevention are confounded by withdrawal effects caused by the drugs.
Gradual Tapering Recommended for Antidepressant Discontinuation
A new literature review reinforces the need to “down-titrate” or taper antidepressants, especially drugs like Celexa and Paxil.
Keys to Successful Discontinuation of Antipsychotic Medication
Qualitative study finds that both internal resources and systemic factors play a role in antipsychotic discontinuation outcomes.
Researchers Provide Guidance for Reducing and Stopping Psychiatric Drugs
New guidance on how to taper and discontinue from psychiatric drugs from leading researchers Mark Horowitz and David Taylor.
How Therapists Can Help With Psychiatric Drug Withdrawal: An Interview With Anne Guy
MIA's Richard Sears interviews psychotherapist Anne Guy about working with clients withdrawing from psychiatric drugs.
Mental Health Staff Reluctant to Support Service Users in Tapering Antipsychotics, Study Finds
Study reveals schizophrenia patients find little support from mental health staff in reducing side effects-heavy drugs.
STOP or GO? Tapering Pregnant Women off of Antidepressants
A team in the Netherlands is currently investigating the effects of tapering off of antidepressants known as selective serotonin reuptake inhibitors (SSRIs) during pregnancy....
Withdrawal Symptoms Cloud Findings of Antidepressant “Relapse” Trial
Leading researchers point out that a new antidepressant study in NEJM failed to account for withdrawal symptoms, casting doubt on the results.
Global Survey Leads to New Recommendations for Deprescribing Psychiatric Drugs
Growing rates of long-term psychiatric drug prescriptions and documented issues with withdrawal demonstrate a need for safe deprescribing practices.
Antidepressant Withdrawal Misdiagnosed as Functional Disorder
Adverse physiological symptoms of antidepressant withdrawal are regularly mistaken to be other problems to the detriment of the patient.
The Ethics of Antipsychotic Dose Reduction and Patient Rights
New research highlights the ethical responsibilities of clinicians in supporting patients who choose to reduce or discontinue antipsychotic medication.
Lack of Guidance Available for Discontinuing Psychiatric Drugs
A new article discusses the lack of research dedicated to discontinuing psychiatric drugs and reviews existing strategies.
Antipsychotic Medications Are Causing Obsessive Compulsive Disorders
Common second-generation antipsychotic medications are causing symptoms of obsessive-compulsive disorder to emerge in many people who previously only had schizophrenia symptoms, according to a...
Research Explores the Experience of Benzodiazepine Withdrawal
A new study reveals many benzodiazepine users are misinformed about the risks of withdrawal and experience devastating consequences.
New Research on Patient-Centered Deprescribing for Antipsychotics
Researchers review the risks and benefits of deprescribing from antipsychotic drugs and advocate for a patient-centered approach to tapering.
Antipsychotic-induced Sexual Dysfunction Underreported
Researchers found some antipsychotics to be worse than others for causing sexual dysfunction.
Researchers: Antidepressant Withdrawal, Not “Discontinuation Syndrome”
Researchers suggest that the pharmaceutical industry had a vested interest in using the term “discontinuation” in order to hide the severity of physical dependence and withdrawal reactions many people experience from antidepressants.
Official Guidelines on Antidepressant Discontinuation Fail Practitioners and Patients
A review of clinical practice guidelines for antidepressant discontinuation from across the English-speaking world reveals major pitfalls.
